Effect of preoperative arterial infusion chemotherapy and chemoradiation therapy for locally advanced resectable pancreatic cancer.

Effect of preoperative arterial infusion chemotherapy and chemoradiation therapy for locally advanced resectable pancreatic cancer. - Effect of arterial infusion chemotherapy and chemoradiation therapy for pancreatic cancer.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012250

Enrollment

Registered

2013-11-15

Start date

2013-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

arterial infusion chemotherapy chemoradiation therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Histologically or cytologically confirmed locally advanced resectable pancreatic cancer Patients should be chemo native Must have evaluable disease by standard radiographic criteria Clinical performance status of ECOG 0, 1, 2 Must be able to take oral ingestion Must be able to understand and sign the Informed Consent Document No history of prior malignancies within the 2 years prior to enrollment

Exclusion criteria

Exclusion criteria: Metastatic disease including malignant ascites

Design outcomes

Primary

Measure	Time frame
response rate	—

Secondary

Measure	Time frame
resection rate	—

Countries

Japan

Contacts

Public ContactYoshiharu Miyamoto

Osaka medical college General and gastroenterological surgery

sur127@poh.osaka-med.ac.jp81-72-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026